Related by context. All words. (Click for frequent words.) 71 S. aureus infections 67 C. difficile infection 66 invasive fungal infections 66 staphylococcal infections 64 S. aureus bacteremia 64 chronic HCV infection 63 Clostridium difficile infection 63 CA MRSA infections 63 C. difficile infections 63 HCV infection 63 candidemia 63 CMV infection 62 linezolid 62 cIAI 62 CMV disease 62 S. aureus 62 immunocompromised patients 61 Clostridium difficile infections 61 MRSA infections 61 tigecycline 61 nosocomial 61 cSSSI 60 bacteremia 60 peginterferon alfa 2a 60 BSIs 60 COPD exacerbations 60 HCV infections 60 bendamustine 60 invasive aspergillosis 60 S. aureus infection 60 Clostridium difficile associated 60 herpes zoster shingles 60 nosocomial pneumonia 60 RSV infections 60 superficial bladder cancer 60 ZYVOX 60 daptomycin 60 mycobacterial infections 60 disease CDAD 60 herpes zoster 60 Staphylococcus aureus infections 60 eosinophilic pneumonia 60 rotavirus diarrhea 60 serotype #A 59 multidrug resistant 59 HAV infection 59 UTIs 59 APTIVUS r 59 C. difficile 59 acute otitis media 59 invasive candidiasis 59 methicillin resistant S. aureus 59 posaconazole 59 bacteraemia 59 superinfection 59 solithromycin 59 RSV infection 59 imipenem 59 CA MRSA 59 infective endocarditis 59 pneumococci 59 HBV infection 59 bacterial pneumonias 59 quinolone 59 H pylori 59 antimicrobial prophylaxis 59 LTBI 59 ESBL producing E. coli 59 hypervirulent strain 58 P. aeruginosa 58 C. difficile colitis 58 chronic GVHD 58 C difficile infection 58 antibiotic prophylaxis 58 recurrent genital herpes 58 HCV genotype 1 58 nosocomial infection 58 varicella infection 58 ADHF 58 MDR tuberculosis 58 S. aureus isolates 58 febrile illness 58 asthma exacerbations 58 dapsone 58 vancomycin 58 metastatic neuroendocrine tumors 58 BARACLUDE ® 58 C. diff infections 58 Altastaph 58 TB MDR TB 58 fluoroquinolone resistant 58 carbapenem resistant 58 EXJADE 58 PREZISTA r 58 hepatitis C genotype 58 fusidic acid 58 ketolide antibiotic 58 NOMID 58 chronic rhinosinusitis 58 C. difficile diarrhea 58 mupirocin 58 Staphylococcus aureus MRSA 58 H. pylori infection 58 micafungin 58 pneumococcal infections 57 falciparum malaria 57 endophthalmitis 57 WNV infection 57 S aureus 57 hepatitis C HCV 57 HCV infected 57 venous blood clots 57 pneumococcal pneumonia 57 strep infections 57 oseltamivir Tamiflu 57 virologic failure 57 C.difficile 57 pneumococcal infection 57 methicillin susceptible Staphylococcus aureus 57 rhinosinusitis 57 MRSA colonization 57 KETEK 57 doripenem 57 nosocomial infections 57 Candida infections 57 antibiotic therapy 57 susceptible isolates 57 Enterococcus faecium 57 invasive MRSA infections 57 INTELENCE 57 ertapenem 57 immunocompetent 57 macrolide resistance 57 onychomycosis 57 chlamydial infections 57 lupus nephritis 57 Bcr Abl mutations 57 latent TB infection 57 delayed CINV 57 Chlamydia trachomatis 57 Candida infection 57 ReA 57 VFEND 57 voriconazole 57 biologic DMARD 57 chronic HBV infection 57 immunosuppressed patients 57 cSSSIs 57 ceftriaxone 57 Salmonella typhi 57 cidofovir 57 chlamydia infection 57 duodenal ulcers 57 severe sepsis 57 invasive fungal infection 57 interstitial pneumonia 56 dengue hemorrhagic fever DHF 56 Acute Bacterial Sinusitis ABS 56 streptococcal infections 56 C. diff 56 chronic HCV 56 Cethromycin 56 fluoroquinolone resistance 56 acute sinusitis 56 NOXAFIL 56 Ceftaroline 56 hyper virulent strain 56 tipranavir 56 chemotherapy induced neutropenia 56 LCMV infection 56 chronic hepatitis B. 56 pH#N# 56 HBeAg positive patients 56 Shigella 56 hypersensitivity reaction 56 efalizumab 56 PegIFN RBV 56 acid suppressive medication 56 Pseudomonas aeruginosa infections 56 adalimumab 56 serogroup C 56 vancomycin resistant 56 ALT flares 56 hypercalcemia 56 postherpetic neuralgia 56 diarrheal illness 56 iclaprim 56 meropenem 56 TMP SMX 56 Clostridium difficile 56 Traficet EN 56 amoxicillin clavulanate 56 Plasmodium falciparum malaria 56 macrolide antibiotics 56 ARCALYST 56 methicillin resistant 56 enterococcal 56 multidrug resistant organisms 56 Listeria infections 56 Chlamydia infections 56 VaD 56 metastatic RCC 56 Onychomycosis 56 respiratory viral infections 56 Community Acquired Pneumonia 56 APTIVUS ritonavir 56 chronic HBV 56 macrolide 56 radezolid 56 systemic lupus erythematosus SLE 56 RMSF 56 hepatocellular carcinoma HCC 56 invasive meningococcal disease 56 acute rheumatic fever 56 VTE 56 pheochromocytoma 56 nonsevere 56 oral vancomycin 56 severe hypersensitivity reactions 56 NeuroStar TMS Therapy 56 Pegasys ® 56 trivalent inactivated influenza 56 MRSA strains 55 S. pneumoniae 55 granisetron 55 recurrent glioblastoma multiforme 55 atherothrombotic disease 55 imatinib resistance 55 postexposure prophylaxis 55 CIMZIA ™ 55 TYGACIL 55 Helicobacter pylori infection 55 ROTARIX 55 pneumonia CAP 55 SHPT 55 levofloxacin 55 Streptococcus pyogenes 55 hepatitis B virus HBV 55 foodborne infections 55 hemagglutination inhibition 55 HBeAg seroconversion 55 chronic hepatitis C. 55 Valortim R 55 genital herpes infections 55 infections cIAI 55 aureus MRSA 55 atopic eczema 55 hepatitis B infection 55 ziconotide 55 post herpetic neuralgia 55 antiviral prophylaxis 55 CRKP 55 indolent NHL 55 invasive pneumococcal disease 55 dengue hemorrhagic fever 55 rhinovirus infection 55 CMV reactivation 55 C. trachomatis 55 SSTIs 55 bloodstream infection 55 gatifloxacin 55 empiric treatment 55 antibiotic vancomycin 55 atopic dermatitis 55 bacteriuria 55 hepatocellular carcinoma 55 relapsed MM 55 GABHS 55 nephrotoxicity 55 cefepime 55 empiric therapy 55 mRCC 55 variceal bleeding 55 VUR 55 candidiasis 55 ceftazidime 55 amphotericin B 55 VZV 55 salmeterol HFA MDI 55 Multidrug resistant 55 chronic hepatitis 55 nitazoxanide 55 leukemia CLL 55 alefacept 55 fungal keratitis 55 T2DM 55 MRSA infection 55 allergen immunotherapy 55 paralytic polio 55 Hib disease 55 viremia 55 Candida species 55 AVELOX 55 acute respiratory tract infections 55 somatostatin analogs 55 Genital herpes 55 M. bovis 55 Escherichia coli Klebsiella pneumoniae 55 medullary thyroid cancer 55 solifenacin 55 recurrent VTE 55 zoster 55 CCR5 tropic HIV 55 OAB symptoms 55 WNV infections 55 renal toxicity 55 vismodegib 55 myiasis 55 CRBSI 55 gonococcal infections 55 pneumonias 55 Bacteremia 55 neuraminidase inhibitor 55 follicular lymphomas 55 severe asthma exacerbations 55 streptococcal 55 bacterial respiratory infections 55 mechanically ventilated patients 55 Enterococci 55 acute gout flares 55 nontuberculous mycobacteria 55 quinolones 55 nucleoside naive 55 APTIVUS 55 hyperammonemia 55 meningoencephalitis 55 heavily pretreated 55 diarrheal disease 55 systemic corticosteroids 54 varicella 54 febrile neutropenia 54 Typhoid fever 54 hemorrhagic cystitis 54 clostridium difficile infection 54 noninfectious uveitis 54 tuberculin skin testing 54 Zavesca ® 54 tinidazole 54 Chronic Prostatitis 54 live attenuated influenza 54 MenB 54 treatment naive genotype 54 nitrofurantoin 54 octreotide LAR 54 JNJ Q2 54 aspergillosis 54 oritavancin 54 sodium stibogluconate 54 seborrheic dermatitis 54 viral subtypes 54 secondary hyperparathyroidism SHPT 54 Acinetobacter infections 54 Enterobacter cloacae 54 hepatotoxicity 54 riociguat 54 immunocompetent patients 54 antiviral therapy 54 octreotide 54 IBS C 54 b Hib 54 S. aureus bloodstream infections 54 Typhimurium 54 rFIXFc 54 adenovirus infections 54 lamivudine 54 Clostridium difficile Infection 54 Herpes zoster 54 ribavirin therapy 54 antibiotics metronidazole 54 REMICADE ® 54 relapsing MS 54 aseptic meningitis 54 PRTX 54 etiologic agent 54 antithrombotics 54 tick borne disease 54 Tindamax R 54 severe rotavirus gastroenteritis 54 HAIs 54 hemorrhagic complications 54 H. pylori 54 gout flare 54 DPNP 54 chronic hepatitis B 54 infections 54 macrolides 54 acute rhinosinusitis 54 MDR TB 54 FluCAM arm 54 biodefense countermeasure 54 causative pathogen 54 empyema 54 invasive pneumococcal diseases 54 Moxifloxacin 54 acute hepatitis 54 pneumococcal meningitis 54 thromboembolic events 54 vaccinees 54 Aspergillus infections 54 immunodeficiency 54 methicillin resistant MRSA 54 CAUTI 54 trimethoprim sulfamethoxazole 54 ALI ARDS 54 influenza 54 immunosuppressive agents 54 Streptococcus pneumoniae pneumococcus 54 NATRECOR ® 54 Tuberculosis MDR TB 54 herpes infections 54 tumor lysis syndrome 54 MRSA Methicillin resistant Staphylococcus 54 alemtuzumab treated 54 vidofludimus 54 Methicillin 54 COPD exacerbation 54 refractory gout 54 N. meningitidis 54 antiretroviral naive 54 chronic hepatitis cirrhosis 54 sustained virological response 54 CRBSIs 54 virus HCV infection 54 intravenous bisphosphonates 54 canakinumab 54 null responder 54 parasitic worm infections 54 Aptivus ® 54 decitabine 54 parainfluenza virus 54 herpes zoster vaccine 54 gonococcal 54 fluconazole 54 Shigella bacteria 54 velafermin 54 mcg dose 54 NAbs 54 mycophenolate mofetil 54 peginterferon 54 microbiological eradication 54 oseltamivir resistance 54 severe neutropenia 54 simplex virus 54 latent tuberculosis infection 54 TEAEs 54 heparin induced thrombocytopenia 54 null responder HCV 54 latent tuberculosis 54 intravesical 54 cytomegalovirus infection 54 chlamydial infection 54 multidrug resistant strains 54 CANCIDAS 54 acute pharyngitis 54 Burkholderia pseudomallei 54 leukemia ALL 54 inhalational anthrax 54 carcinoid tumors 54 chlamydial 54 rotavirus infection 54 Multi Drug Resistant 54 mucositis 54 virologic breakthrough 54 endometrial hyperplasia 54 suppressive therapy 54 oropharyngeal candidiasis 54 cholangiocarcinoma 54 bacterium Neisseria meningitidis 54 Hydroxyurea 54 HBV infections 54 cryptococcal meningitis 54 BI/NAP#/# 54 norovirus infection 54 Mycoplasma pneumoniae 54 LEVAQUIN 54 quinolone antibiotics 54 docetaxel Taxotere ® 54 Dengue virus 54 antibiotic resistant bacterial infections 54 MRSA methicillin resistant Staphylococcus 54 heterozygous FH 54 Noxafil 54 ALT elevations 54 VP# [004] 54 methicillin resistant Staphylococcus aureus 54 bacterial sinusitis 54 entecavir 54 N. gonorrhoeae 54 atopic 54 Thrombocytopenia 54 Aspergillosis 54 oral antiviral 54 rotavirus gastroenteritis 54 antifungal therapy 54 PTLD 53 anaphylactic reactions 53 Antibiotic resistant infections 53 MRSA bacteraemia 53 quinolone resistant 53 linezolid resistant 53 pegylated interferon 53 opportunistic pathogens 53 infliximab 53 piperacillin tazobactam 53 SCCHN 53 BRSV 53 Nosocomial 53 DOXIL 53 Primary IGFD 53 genital ulcers 53 penicillin resistant 53 uncomplicated malaria 53 Chronic sinusitis 53 Lyme arthritis 53 mediastinitis 53 C. diff infection 53 INVEGA ® 53 hypereosinophilic syndrome 53 babesiosis 53 thrombotic events 53 sepsis 53 macrolide resistant 53 enterotoxigenic E. coli 53 Pentacel vaccine 53 chronic ITP patients 53 post herpetic neuralgia PHN 53 severe oral mucositis 53 chlorambucil 53 eczema vaccinatum 53 Lactic acidosis 53 pancreatic adenocarcinoma 53 prophylaxis 53 Chronic hepatitis C 53 tocilizumab 53 chorioamnionitis 53 TORISEL 53 AA Amyloidosis 53 myopathy rhabdomyolysis 53 viral hemorrhagic fever 53 immunosuppressed 53 INVANZ 53 schistosomiasis 53 delafloxacin 53 HCV genotypes 53 antiviral efficacy 53 HCV SPRINT 53 vancomycin resistant enterococci VRE 53 leukotriene receptor antagonists 53 MRSA isolates 53 relapsing remitting 53 DEFLUX 53 pentoxifylline 53 fluoroquinolone antibiotic 53 HBeAg positive 53 diaper dermatitis 53 USA# strain 53 chemoprophylaxis 53 serogroups 53 azithromycin 53 proctitis 53 varicella zoster virus VZV 53 serotypes 53 immunosuppressives 53 leukemia AML 53 FVIII inhibitors 53 rotaviruses 53 H. influenzae 53 LAIV 53 liposomal amphotericin B 53 gemifloxacin 53 XDR tuberculosis 53 ARIXTRA 53 seroprotection 53 infection 53 ZOSTAVAX 53 Hospital Acquired Infections 53 neuropsychiatric symptoms 53 Bloodstream infections 53 combination antiretroviral therapy 53 asthma exacerbation 53 Enterobacteriaceae 53 seroconversion 53 surgical prophylaxis 53 dengue haemorrhagic fever 53 Dengue Hemorrhagic Fever 53 P. vivax malaria 53 Exacerbations 53 macrolide antibiotic 53 gastric adenocarcinoma 53 rilonacept 53 seasonal influenza 53 endotoxemia 53 P aeruginosa 53 hydroxychloroquine 53 zoonotic disease 53 relapsed CLL 53 HBeAg negative 53 pseudomembranous colitis 53 oral candidiasis 53 pancreatic neuroendocrine tumors 53 necrotizing pancreatitis 53 tacrolimus ointment 53 Streptococcus pneumoniae Haemophilus influenzae 53 Chlamydia infection 53 oseltamivir resistant 53 hypomagnesemia 53 angioedema 53 ESRD patients 53 streptococcal disease 53 Nosocomial infections 53 inactivated influenza vaccine 53 rotavirus strains 53 multidrug resistance 53 protease inhibitors PIs 53 resistant Staphylococcus aureus MRSA 53 Toxicities 53 PCV7 vaccine 53 basiliximab 53 immunosuppressive therapies 53 ACTEMRA TM 53 therapeutic regimens 53 Norovirus infection 53 refractory NSCLC 53 asymptomatic carriers 53 chronic ITP 53 sJIA 53 hypervirulent strains 53 allergic rhinitis 53 dengue epidemics 53 COPD 53 upper gastrointestinal bleeding 53 diabetes mellitus DM 53 SCH # 53 hyperprolactinemia 53 VAPRISOL 53 vWD 53 renal tumors 53 postoperative nausea 53 Cariprazine 53 C.difficile infections 53 resistant microorganisms 53 coccidiosis 53 treatment naïve genotype 53 immuno compromised patients 53 glucocorticoid therapy 53 diarrhea CDAD 53 oral FTY# 53 HPAI 53 MDRTB 53 P. aeruginosa infections 53 HBV 53 diarrheal 53 HCV 53 WNV encephalitis 53 posterior uveitis 53 pneumocystis pneumonia 53 postoperative infections 53 venous thrombosis 53 antibody titers 53 MRSA 53 Campylobacter 53 C. gattii 53 uncomplicated influenza 53 Pentacel R 53 acute onset CINV 53 S. suis 53 ARIKACE 53 refractory CLL 53 CCR5 tropic 53 ESBLs 53 oral rivaroxaban 53 AGILECT R 53 uncontrolled asthma 53 NNRTI resistance 53 Lactobacillus KW 53 certolizumab pegol 53 hepatorenal syndrome 53 EBV infection 53 TransVax ™ 53 Chronic Fatigue Syndrome CFS 53 tuberculosis TB 53 Cryptococcus neoformans 53 pyelonephritis 53 Antibiotic resistance 53 esophagitis 53 Moraxella catarrhalis 53 Borrelia 53 Acinetobacter 53 adrenal insufficiency 53 Allergic Rhinitis 53 Cimzia ® 53 DVT PE 53 calcineurin inhibitors 52 Typhi 52 artemisinin resistance 52 human metapneumovirus 52 atrophic gastritis 52 type 1diabetes 52 viral kinetics 52 acute humoral rejection 52 Vibrio infections 52 EoE 52 antiviral therapies 52 dengue haemorrhagic fever DHF 52 vivax 52 peritumoral brain edema 52 neutropenic patients 52 lichen planus 52 K. pneumoniae 52 cryptococcosis 52 ocular toxicity 52 stable angina 52 beta lactam antibiotic 52 STELARA 52 acid suppressive drugs 52 recurrent glioma 52 HIV coinfected 52 Teriflunomide 52 HIB vaccine 52 nosocomial hospital 52 cerebral vasospasm 52 C diff infection 52 PCV7 52 P. falciparum malaria 52 PCV# 52 pneumococcal serotypes 52 Haemophilus influenzae 52 HPV-#/# 52 sulfasalazine 52 adefovir 52 meningococcus 52 anterior uveitis 52 pyrazinamide 52 cutaneous anthrax 52 antibiotic regimens 52 SPRYCEL ® 52 postoperative atrial fibrillation 52 Telbivudine 52 infectious mononucleosis 52 precancerous cervical lesions 52 biologic therapy 52 Helicobacter pylori H. pylori 52 malignant pleural mesothelioma 52 exacerbations 52 meningococcal infection 52 urinary incontinence UI 52 Respiratory Syncytial Virus RSV 52 osteoporotic fractures 52 aldosterone antagonist 52 acute leukemia AML 52 corticosteroid therapy 52 progressive PsA 52 venous thromboembolism VTE 52 aztreonam 52 injectable formulations 52 pulmonary exacerbations 52 bacterial vaginosis 52 Streptococcus pneumonia 52 Levofloxacin 52 tuberculous 52 Vfend 52 acne vulgaris 52 BARACLUDE R 52 antiplatelet medications 52 Chlamydia pneumoniae 52 protease inhibitor PI 52 feline distemper 52 Natalizumab 52 Hepatocellular Carcinoma HCC 52 giardiasis 52 Respiratory syncytial virus RSV 52 venomous snakebites 52 romiplostim 52 ano genital warts 52 aureus infections 52 forodesine 52 paroxysmal AF 52 caspofungin 52 Salmonella Campylobacter 52 Streptococcus pneumoniae 52 metastatic malignant melanoma 52 glucocorticoid induced osteoporosis 52 juvenile idiopathic arthritis JIA 52 C. Diff 52 antibiotic resistant infections 52 Vaprisol 52 tipranavir ritonavir 52 Rimantadine 52 receiving VELCADE 52 ribavirin RBV 52 immune thrombocytopenic purpura ITP 52 herpes zoster virus 52 chronic urticaria 52 venous thromboembolic events 52 Staphylococcal infections 52 PAOD 52 hypersensitivity allergic reactions 52 DAPT 52 NRTI resistance 52 glatiramer acetate 52 Candidiasis 52 Hepatitis C virus HCV 52 inhibitor RG# 52 S. aureus bacteria 52 Haptoglobin 52 elevated ALT 52 external genital lesions 52 falciparum 52 Renal impairment 52 virological failure 52 post surgical adhesions 52 pulmonary TB 52 Avelox 52 venous thromboembolism 52 herpes labialis 52 renal scarring 52 serum antibody 52 primary immunodeficiency PI 52 MGUS 52 gouty arthritis 52 pneumococcal vaccination 52 Salmonella infections 52 haloperidol Haldol 52 cephalosporin antibiotic 52 nucleotide analog 52 BARACLUDE resistance 52 pimecrolimus 52 opportunistic pathogen 52 Atopic dermatitis 52 thromboprophylaxis 52 HPAI H#N# 52 plasma kallikrein 52 resistant S. aureus 52 transaminase elevations 52 polymicrobial infections 52 PEGylated interferon beta 1a 52 Thiovir 52 resistant strains 52 urethritis 52 thromboembolism 52 metastatic lung cancer 52 esophageal candidiasis 52 serogroup 52 pertussis 52 vaccine LAIV 52 relapsing remitting MS RRMS 52 adenovirus infection 52 pancreatic NET 52 causative pathogens 52 desmopressin 52 dengue viruses 52 co trimoxazole 52 methicillin 52 novel H#N# influenza 52 GnRH agonists 52 Clostridium difficile C. difficile 52 intravenous vancomycin 52 nonmelanoma skin cancer 52 pertussis whooping cough 52 relapsing remitting multiple sclerosis 52 postexposure 52 IMGN# 52 necrotizing pneumonia 52 Valcyte 52 fidaxomicin 52 ADPKD 52 azacitidine 52 chronically infected 52 neutropenic 52 CIPN 52 serologic 52 active ankylosing spondylitis 52 Chronic lymphocytic leukemia 52 telithromycin 52 E. coli STEC 52 acute PAO 52 hemolytic uremic syndrome HUS 52 S.aureus 52 systemic fungal infections 52 zidovudine AZT 52 swine origin 52 FASLODEX 52 Salmonella infection 52 anagrelide 52 virological response 52 virus HBV 52 Venous thromboembolism 52 acute GvHD 52 systemic scleroderma 52 A. flavus 52 Human papilloma virus 52 rFVIIa 52 severe exacerbations 52 certolizumab 52 thromboembolic disease 52 chronic periodontitis 52 Infusion Reactions Severe 52 serologically active patients 52 FluCide 52 vinorelbine 52 acute HAE attacks 52 interstitial lung disease 52 symptomatic BPH 52 enteroviruses 52 infectious syphilis 52 divalproex sodium 52 BARACLUDE 52 Alinia 52 HPV infections 52 ischemic colitis 52 relapsed SCLC 52 ritonavir boosted 52 COPAXONE R 52 abatacept 52 RAPTIVA 52 administered concomitantly 52 DLBCL 52 Klebsiella pneumoniae 52 Virologic failure 52 ganciclovir 52 HeFH 52 herpesviruses 52 pomalidomide 52 achieve sustained virologic 52 relapsed multiple myeloma 52 stage IIIB 52 prucalopride 52 methicillin resistance 52 plus ribavirin 52 infectious gastroenteritis 52 Omalizumab 52 DDP# 52 myeloproliferative disorders 52 bloodstream infections 52 ankylosing spondylitis AS 52 serotype 52 Bronchiolitis 52 oral antifungal 52 resistant TB 52 diabetic gastroparesis 52 Chronic Hepatitis B 52 RSV hospitalizations 52 cystic fibrosis bronchiectasis 52 bexarotene 52 vancomycin resistant enterococci 52 CIMZIA TM 52 EGFR antibodies 52 constipation OIC 52 Extensively drug 52 serogroup B 52 Febrile neutropenia 52 delayed onset CINV 52 cirrhotic patients 52 dermatophytes 52 pulmonary hypertension PH 52 methicillin susceptible S. aureus 51 malignant neoplasms 51 keloid formation 51 varicella vaccine 51 tick borne illnesses 51 orchitis 51 Chlamydophila pneumoniae 51 Anaplasma 51 enfuvirtide 51 concomitant antibiotics 51 Acinetobacter baumannii 51 H#N# Influenza virus 51 S. enterica 51 DAS# [001] 51 Copegus ribavirin 51 coccidia 51 PPSV# 51 atopy 51 palivizumab 51 Cimzia R 51 noroviruses 51 GI motility disorders 51 bacterial sepsis 51 acid suppressive therapy 51 anakinra 51 herpes zoster infection 51 gastrointestinal adverse reactions 51 HPA axis suppression 51 lumiliximab 51 PONV 51 vaccine serotypes 51 haemolytic anemia 51 peginterferon alfa 2a #KD 51 swine dysentery 51 diabetic neuropathic pain 51 serologically 51 Neisseria gonorrhoeae 51 neutropenia dehydration dyspnea 51 virus RSV 51 Staph infections 51 acid suppressive medications 51 viral conjunctivitis 51 rifampin 51 HBV vaccine